New drug cocktail shows promise in tough pancreatic cancer trial
Disease control
Completed
This study tested a combination of two drugs, cabozantinib and pembrolizumab, in 21 people with metastatic pancreatic cancer that had worsened after standard treatments. The goal was to see if the combo could slow cancer growth or shrink tumors. While not a cure, the approach aim…
Phase: PHASE2 • Sponsor: Joseph Kim • Aim: Disease control
Last updated May 04, 2026 16:31 UTC